Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Full dose subcutaneous heparin therapy.

G Hollander, R Rothenberg, A Greengart

New York State Journal of Medicine

|July 1, 1989

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Non-pharmaceutical interventions in the State of Georgia: Economic implications.

Ethics, medicine, and public health·2023

Same author

Should COVID-19 patients >75 years be Ventilated? An Outcome Study.

QJM : monthly journal of the Association of Physicians·2021

Same author

Corrigendum to: Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study.

QJM : monthly journal of the Association of Physicians·2021

Same author

Evaluation of urethral orifice cross-section dimensions following perineal urethrostomy in male cats.

The Journal of small animal practice·2020

Same author

Outcomes in patients with severe COVID-19 disease treated with tocilizumab: a case-controlled study.

QJM : monthly journal of the Association of Physicians·2020

Same author

Real-time forecasts of the COVID-19 epidemic in China from February 5th to February 24th, 2020.

Infectious Disease Modelling·2020

Same journal

Ovarian cyst in the content of inguinal hernial sac.

New York state journal of medicine·2010

Same journal

Para-esophageal hiatal hernia; a case manifesting gastrointestinal and cardiac symptoms and presenting itself on x-ray as a mediastinal tumor.

New York state journal of medicine·2010

Same journal

Occult maxillary antrum infection.

New York state journal of medicine·2010

Same journal

Proctoscopy and barium colon study in the diagnosis of rectal conditions.

New York state journal of medicine·2010

Same journal

The prognostic value of the sodium amytal test in hypertension managed by thoracolumbar sympathectomy.

New York state journal of medicine·2010

Same journal

A report on poliomyelitis cases from the Hospital for Special Surgery of New York City.

New York state journal of medicine·2010

See all related articles

Subcutaneous heparin offers a safe and effective alternative to continuous intravenous infusions for anticoagulation in myocardial infarction patients. This method reduces complications and provides significant cost savings.

Area of Science:

Cardiology
Pharmacology
Health Economics

Background:

Anticoagulation is crucial for managing thromboembolic disorders.
Continuous intravenous heparin infusion is standard but poses challenges.
Subcutaneous heparin presents a potential alternative for full-dose anticoagulation.

Purpose of the Study:

To evaluate the safety and efficacy of full-dose subcutaneous heparin.
To assess the cost-effectiveness of subcutaneous versus intravenous heparin administration.

Main Methods:

A study involving fifteen hospitalized myocardial infarction patients.
Transitioning patients from continuous intravenous heparin to subcutaneous heparin therapy.
Monitoring for complications and comparing administration routes.

Related Experiment Videos

Main Results:

Subcutaneous heparin administration was associated with minimal complications, primarily local hematomas.
Therapeutic anticoagulation was successfully maintained via the subcutaneous route.
Significant cost reductions were observed with subcutaneous heparin administration compared to intravenous therapy.

Conclusions:

Full-dose subcutaneous heparin is a safe and effective method for anticoagulation in myocardial infarction patients.
This administration route offers a more convenient and cost-effective alternative to continuous intravenous infusions.
Subcutaneous heparin warrants consideration for routine clinical practice in relevant patient populations.